AKHNATON

Egypt
Total Awarded$4.9MSee the contracts
Contract Awards52

About AKHNATON

No description has been published for this company. If it is yours you can claim the profile and propose one. A member of staff reads every claim.

Contract Awards

52 public contracts recorded as awarded to AKHNATON, worth $4.9M in total. Every entry links to the record it came from, so it can be checked at the source.

Source for every entry below: World Bank Contract Awards Dataset (DS00005)

Jun 24, 2021Egypt
Purchasing virus C drugs to Heart and Liver Research Center in Kafr El-Sheikh for the treatment of C virus . This is a fixed dose combination drug. Each tablet Tecavir 1mg$95K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-228296-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$95K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164734-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$96K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164698-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$97K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164700-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of Sofosbuvir and 100 mg of Velpatasvir.$97K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164742-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$92K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164746-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$95K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164750-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$90K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164749-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$95K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164752-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$89K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164738-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Show all 50 awards(40 more)
May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$96K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164685-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$94K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164741-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$96K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164701-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$92K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164753-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$97K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164751-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$85K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164735-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$96K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164755-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$96K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164694-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$96K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164762-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$96K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164697-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$97K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164760-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$97K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164761-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$96K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164690-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$96K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164757-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$97K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164745-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$96K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164692-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$89K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164740-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$96K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164695-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$94K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164739-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$97K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164758-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$92K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164737-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

May 17, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$92K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-164736-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Feb 12, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$101K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-153060-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Feb 12, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$101K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-153086-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Feb 12, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$101K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-153083-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Feb 12, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$100K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-153087-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Feb 12, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$100K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-153059-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Feb 12, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$100K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-153062-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Feb 12, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$100K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-153066-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Feb 12, 2020Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$100K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-153063-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Dec 29, 2019Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$99K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-143439-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Dec 29, 2019Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$99K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-143440-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Dec 29, 2019Egypt
the currently used drugs through the Egyptian national treatment program are combination of Sofosbuvir 400mg+ Daclatasvir 60 mg for 12 weeks .$99K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-143441-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Nov 13, 2019Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$98K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-143435-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Nov 13, 2019Egypt
Purchase of Hepatitis c drugs for the treatment of patients who did not respond to prior direct-acting antiviral therapy according to the protocol approved by the NCCVH$98K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-143430-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Nov 13, 2019Egypt
Purchase of Hepatitis c drugs for the treatment of patients who did not respond to prior direct-acting antiviral therapy according to the protocol approved by the NCCVH$98K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-143443-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Nov 13, 2019Egypt
Purchase of Hepatitis c drugs for the treatment of patients who did not respond to prior direct-acting antiviral therapy according to the protocol approved by the NCCVH$98K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-143431-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Nov 13, 2019Egypt
Purchase of Hepatitis c drugs for the treatment of patients who did not respond to prior direct-acting antiviral therapy according to the protocol approved by the NCCVH$99K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-143438-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Nov 13, 2019Egypt
Purchase of Hepatitis c drugs for the treatment of patients who did not respond to prior direct-acting antiviral therapy according to the protocol approved by the NCCVH$5K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-143432-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Nov 13, 2019Egypt
Purchase of Hepatitis c drugs for the treatment of patients who did not respond to prior direct-acting antiviral therapy according to the protocol approved by the NCCVH$98K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-143434-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Showing the 50 most recent. 2 further awards are recorded and not listed here.

Is this you?

Claiming starts a review. A member of staff reads it, and nothing on this profile changes until they decide.

Claim this business
Report an error

Contact

No contact info available yet

Quick Facts

CountryEgypt

More companies in Egypt

See all
IBNSINAPHARMA
Egypt
SME
Wadi Food IndustriesPremium Egyptian olive oil
Alexandria
Non-profit
Bibliotheca AlexandrinaRevival of the Ancient Library
Alexandria
Non-profit
Grand Egyptian MuseumWorld's largest archaeological museum
Giza
Non-profit
Abu Simbel TemplesRamesses II UNESCO site
Abu Simbel
Corporate
Faragalla GroupEgyptian beverages since 1956
Alexandria